Deal Snapshot
Biocare Medical Acquires Empire Genomics to Expand Molecular Portfolio with Addition of Biomarker Development
Wednesday 23 November 2022

California-based biotech company Biocare Medical, providing immunohistochemistry and FISH (Fluorescent in situ hybridisation) instrumentation and reagents, has acquired US-based cancer molecular diagnostics company Empire Genomics, to aid in cancer research and diagnostics, the company said.

Terms of the transaction were not disclosed.

Date Published: 23/11/2022